Two purchases (VB, IUSN.DE) and the ETF-of-the-Month spotlight (SCOW) are Positive. Existing book holdings disclosed with their purchase history are Neutral — they are reported, not re-rated. ETFs get SA·STK research links (Qualtrim has no fund pages); European lines link to their local listing. The WisdomTree Emerging Markets Multifactor, Tema Durable Quality, iShares S&P 500 Equal Weight, iShares Edge MSCI World Multifactor and iShares Core MSCI Emerging Markets lines are named in the transaction sheets without tickers and are left to the talking points, as are SCOW's top-ten underlying holdings. Written post with no timestamps — the At link opens the article.
| Ticker | Name | Research | View | What he said | At |
|---|---|---|---|---|---|
| SCOW | Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF | SA · STK | Positive | ETF of the Month (spotlight) — not purchased. TER 0.59%, physical, ISIN US69374H2206, "only available for investors in North America." The screen is three-stage: "The ETF looks at 600 small American companies. It only selects the ones that have been profitable 7 years in a row," then ranks on "How much cash does the company keep from every dollar it makes?" and "How good is the company at turning money into more cash?", and "finally, the ETF buys the 80 best companies." Result: "Much higher profit margins" and "much better capital allocation skills (high ROIC)" than the average S&P 600 constituent. Information Technology 25.75% and Financials 23.97% are almost half the fund; the top ten are 39.44% of it. | read ↗ |
| VB | Vanguard Small-Cap ETF | SA · STK | Positive | BOUGHT — $500 at tomorrow's open, stated price $278. The American half of the small-cap add, taken on the 25-year-wide valuation gap ("Small Caps: 32% cheaper than large caps"). The fourth purchase of this line: December 2023 at $212.8 (+30.35%), March 2024 at $224.6 (+23.51%) and October 2024 at $242.7 (+14.27%), all now marked at $277.35 — so the add is at the highest price of the four, into the cheapest relative valuation. | read ↗ |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | STK | Positive | BOUGHT — €500 at tomorrow's open, stated price €8.36. The non-American twin of the VB purchase; the split exists purely for access ("If you live in the US, you can't buy non-US ETFs. And if you live outside the US, you can't buy US ETFs"). Also its fourth purchase: November 2023 at €5.62 (+46.51%), April 2024 at €6.37 (+29.24%) and October 2024 at €6.85 (+20.20%), all marked at €8.23 — note the marked price is below the €8.36 he is paying. | read ↗ |
| RSP | Invesco S&P 500 Equal Weight ETF | SA · STK | Neutral | Disclosed holding, not re-rated. The American book's oldest and best position: bought October 2023 at $140.3 (+44.16%), May 2024 at $164.0 (+23.36%) and July 2025 at $184.75 (+9.48%), marked at $202.26. Three of seventeen transactions in the book. | read ↗ |
| MOAT | VanEck Morningstar Wide Moat ETF | SA · STK | Neutral | Disclosed holding, not re-rated. Two purchases: November 2023 at $73.5 (+43.58%) and April 2024 at $85.8 (+23.02%), marked at $105.53 — the second-best line in the American book. It is topped up again in May and August. | read ↗ |
| XMHQ | Invesco S&P MidCap Quality ETF | SA · STK | Neutral | Disclosed holding, not re-rated. Two purchases: January 2024 at $89.4 (+21.87%) and July 2024 at $96.9 (+12.48%), marked at $108.95. The mid-cap expression of the same size-plus-quality idea the SCOW spotlight argues for at the small end. | read ↗ |
| USMV | iShares MSCI USA Min Vol Factor ETF | SA · STK | Neutral | Disclosed holding, not re-rated. The American book's weakest line: one purchase, April 2025 at $90.70, marked at $96.03 for +5.88%. It is topped up in July 2026 on an explicit high-vol/low-vol spread argument. | read ↗ |
| GOAT.AS | VanEck Morningstar Global Wide Moat UCITS ETF | STK | Neutral | Disclosed holding, not re-rated. Three purchases: December 2023 at €23.58 (+38.57%), March 2024 at €25.25 (+29.40%) and March 2025 at €29.50 (+10.76%), marked at €32.67. The non-American twin of MOAT. | read ↗ |
| MVOL.L | iShares Edge MSCI World Minimum Volatility UCITS ETF | STK | Neutral | Disclosed holding, not re-rated. Two purchases: April 2025 at €62.63 (+19.91%) and August 2025 at €62.32 (+20.51%), marked at €75.10. The non-American twin of USMV — and notably far ahead of it, the widest divergence between the paired books. | read ↗ |
Stance = how each line is framed in this post. Five ETFs appear in the transaction sheets under fund names without tickers (WisdomTree Emerging Markets Multifactor, Tema Durable Quality, iShares S&P 500 Equal Weight, iShares Edge MSCI World Multifactor, iShares Core MSCI Emerging Markets) and are covered in the talking points rather than given rows. SCOW's disclosed top-ten holdings — Jackson Financial, InterDigital, MarketAxess, Enova, Etsy, Enphase, Magnolia Oil & Gas, Bread Financial, Box, NMI — are the fund's positions, not Compounding Quality's, and are likewise left to the talking points.
A jargon-free summary of the thesis behind each argued line. (Renders on each name's consolidated page.)
The idea behind this fund is a fix for a known problem. Small companies have historically beaten large ones — by about 1.8% a year, which compounds into a large gap over twenty years — and they are currently cheaper relative to large companies than at any point in 25 years. But the usual way to buy them, a broad small-cap index like the Russell 2000, hands you the loss-makers along with the bargains.
SCOW screens them out in three steps. It starts from 600 small American companies, keeps only those that have made money seven years running, then ranks the survivors on two things: how much of each dollar of sales they keep as cash, and how much extra cash they generate from the money they invest. The best 80 make the fund. The result is a portfolio with much higher margins and much better returns on capital than the average small company — a "Small-High Quality" screen rather than a size bet.
Two things to weigh. The fund costs 0.59% a year, which is expensive against a plain index fund, and it is concentrated: technology and financials are almost half of it, and the ten largest positions are nearly 40%. Also worth noticing — Slegers spotlights it but does not buy it. He cites availability (North America only), and buys two ordinary small-cap funds instead.
VB owns a broad slice of small American companies at very low cost. The $500 added here is the fourth purchase of this line since December 2023, and it is bought on a relative-value argument rather than a forecast: small companies are about 32% cheaper than large ones, a gap that has not been this wide in 25 years, and that used to run the other way — smaller companies traded at a premium from 2004 to 2020.
One honest tension sits inside the issue. The essay spends most of its length arguing that a plain small-cap index is the wrong way to express this, because it includes too many unprofitable businesses — and then the money goes into a plain small-cap index anyway. The previous three purchases are up 30%, 24% and 14%, and this one goes in at the highest price of the four.
This is the European-domiciled twin of the VB purchase — €500 into small companies worldwide rather than only in the US. It exists as a separate line purely because of access rules: American investors cannot buy European funds and Europeans cannot buy American ones, so every transaction in this newsletter comes in matched pairs.
It is the fourth purchase of the line since November 2023, and the earlier ones are up 47%, 29% and 20%. Small detail worth noting: the fund is marked at €8.23 in the same sheet that quotes the new purchase at €8.36 — a reminder that these transaction tables are snapshots taken on different days.
Summary derived from the archived Compounding Quality post (text and transcribed spreadsheet images in transcript.txt) for personal study. Not investment advice. © Compounding Quality / Pieter Slegers for source material.